Industrial Accident at Stryker Cork Leaves Two Hospitalised
April 19, 2023

Trending News 🌧️
Stryker Corporation ($NYSE:SYK) is a leading medical technology company that develops, manufactures and markets innovative medical devices and equipment. The incident occurred in the Cork plant’s production area, where two employees were injured. It is unclear what caused the accident or how serious the injuries were. The Health and Safety Authority have launched an investigation into the incident.
Stryker Corporation has expressed their sympathy towards the injured individuals and their families, and their commitment to the safety of their employees. They have promised a full investigation into the cause of the accident and are taking all necessary steps to ensure a similar incident will not occur in the future.
Share Price
The incident occurred while a piece of machinery was being operated and the cause is currently under investigation. As a result of this news, the company’s stock opened at $294.5 and closed at $290.9, a decrease of 0.6% from its previous closing price of 292.8. This marks the first major accident at the site and has caused concern among investors and workers’ safety advocates alike. It is not yet known what impact this incident will have on the company’s operations or stock price in the near future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Stryker Corporation. More…
| Total Revenues | Net Income | Net Margin |
| 18.45k | 2.36k | 13.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Stryker Corporation. More…
| Operations | Investing | Financing |
| 2.62k | -2.92k | -749 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Stryker Corporation. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 36.88k | 20.27k | 43.5 |
Key Ratios Snapshot
Some of the financial key ratios for Stryker Corporation are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 7.4% | 1.5% | 16.5% |
| FCF Margin | ROE | ROA |
| 11.0% | 11.5% | 5.2% |
Analysis
GoodWhale’s analysis of STRYKER CORPORATION indicates a medium risk investment for its financial and business aspects. We assess the Risk Rating of STRYKER CORPORATION using a combination of information from its financial statements, as well as our proprietary analytical models. While we have identified 1 risk warning in its balance sheet, you can register with us to gain access to this information. GoodWhale also enables deeper insights into STRYKER CORPORATION’s financial health through forward-looking graphical analysis and predictive modelling. To make the most informed decisions, we recommend that you always look at the historical and future trends of your investments. More…

Peers
Stryker Corporation is one of the world’s largest medical technology companies. It offers a broad range of products including orthopedic implants, surgical instruments, medical equipment and software solutions. The company operates in over 100 countries and has a strong presence in the United States, Europe and Asia. Stryker’s competitors include Fukuda Denshi Co Ltd, Nihon Kohden Corp and Shanghai Sanyou Medical Co Ltd.
– Fukuda Denshi Co Ltd ($TSE:6960)
Fukuda Denshi Co. Ltd., together with its subsidiaries, manufactures and sells medical electronic equipment in Japan and internationally. The company operates through five segments: Diagnostic Cardiology, Diagnostic Imaging, Patient Monitoring, Electrotherapy, and Others. It offers diagnostic cardiology products, including electrocardiographs, stress test systems, Holter systems, ambulatory blood pressure monitors, and medical printers; and diagnostic imaging products comprising X-ray diagnostic systems, computed tomography systems, magnetic resonance imaging systems, ultrasound diagnostic systems, X-ray angiography systems, and nuclear medicine diagnostic systems. The company also provides patient monitoring products, such as central station systems, telemetry systems, patient monitors, and related accessories; electrotherapy products, such as shortwave diathermy machines and physical therapy equipment; and other products, such as endoscopic and ophthalmologic equipment. It sells its products primarily to general hospitals, clinics, and other health care facilities. The company was founded in 1930 and is headquartered in Tokyo, Japan.
– Nihon Kohden Corp ($TSE:6849)
Nihon Kohden Corp. is a Japanese manufacturer of medical equipment, headquartered in Tokyo. The company was founded in 1952 and has since grown to become a leading supplier of medical equipment in Japan. Nihon Kohden’s product lineup includes everything from patient monitors and electrocardiographs to ultrasound machines and medical robotics. The company also offers a wide range of services, including maintenance and repair services for its products.
Nihon Kohden has a market capitalization of 269.63 billion as of 2022. The company’s return on equity is 11.49%. Nihon Kohden is a leading manufacturer of medical equipment in Japan. The company offers a wide range of products and services, including maintenance and repair services for its products.
– Shanghai Sanyou Medical Co Ltd ($SHSE:688085)
Shanghai Sanyou Medical Co Ltd is a medical company with a market cap of 6.32B as of 2022. The company’s return on equity is 8.85%. Shanghai Sanyou Medical Co Ltd is engaged in the research, development, manufacture, and sale of medical devices and equipment. The company’s products include medical imaging equipment, medical consumables, and medical disposables.
Summary
Stryker Corporation is a leading medical technology company with a wide range of products and services that span from surgical equipment to medical and surgical supplies. Analysts believe that Stryker is well positioned to benefit from increased demand for medical technology and will continue to deliver above-average returns in the long term.
Recent Posts









